Selective oestrogen receptor modulators (SERMs) for prevention of breast cancer
Powles, T.J.
National Medical Journal of India 26(4): 194-196
2013
ISSN/ISBN: 0970-258X PMID: 24758440 Document Number: 666915
Document emailed within 1 workday
Related Documents
Matsumoto, T. 2006: Selective estrogen receptor modulators (SERMs) Clinical Calcium 16(9): 1520-1525Terán Dávila, J.é; Teppa Garrán, A.D. 2005: Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology Ginecologia y Obstetricia de Mexico 73(8): 424-435
Picariello, L.; Fiorelli, G.; Martineti, V.; Tognarini, I.; Pampaloni, B.; Tonelli, F.; Brandi, M.Luisa. 2003: Growth response of colon cancer cell lines to selective estrogen receptor modulators Anticancer Research 23(3b): 2419-2424
Casey, A. 1981: Oestrogen receptor and breast cancer Nursing Times 77(16): 693-694
McGuire, W.L.; Chamness, G.C.; Fuqua, S.A. 1992: The importance of normal and abnormal oestrogen receptor in breast cancer Cancer Surveys 14: 31-40
Nicholson, R.I.; Bouzubar, N.; Walker, K.J.; McClelland, R.; Dixon, A.R.; Robertson, J.F.; Ellis, I.O.; Blamey, R.W. 1991: Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation European Journal of Cancer 27(7): 908-913
Whitaker, L.H.R.; Williams, A.R.W.; Critchley, H.O.D. 2014: Selective progesterone receptor modulators Current Opinion in Obstetrics and Gynecology 26(4): 237-242
Coombes, R.C.; Powles, T.J.; Berger, U.; Wilson, P.; McClelland, R.A.; Gazet, J.C.; Trott, P.A.; Ford, H.T. 1987: Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates Lancet 2(8561): 701-703
Alfred, R.; Chin, S.N.; Williams, E.; Walters, C.; Barton, E.N.; Shah, D. 2012: The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica West Indian Medical Journal 61(8): 795-801
Martin, J.H.; McKibben, B.M.; Lynch, M.; van den Berg, H.W. 1991: Modulation by oestrogen and progestins/antiprogestins of alpha interferon receptor expression in human breast cancer cells European Journal of Cancer 27(2): 143-146
Benagiano, G.; Bastianelli, C.; Farris, M.; Brosens, I. 2014: Selective progesterone receptor modulators: an update Expert Opinion on PharmacoTherapy 15(10): 1403-1415
Benagiano, G.; Bastianelli, C.; Farris, M. 2008: Selective progesterone receptor modulators 2: use in reproductive medicine Expert Opinion on PharmacoTherapy 9(14): 2473-2485
Meczekalski, B.ła.; Czyzyk, A. 2009: Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis Ginekologia Polska 80(3): 213-217
Imai, Y.; Kato, S. 2010: Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator Clinical Calcium 20(3): 339-344
Sarvilinna, N.; Unkila-Kallio, L.; Härkki, P.äi.; Tiitinen, A.; Heikinheimo, O. 2017: Selective progesterone receptor modulators: new possibilities for gynecologic hormone therapy Duodecim; Laaketieteellinen Aikakauskirja 133(1): 27-33
Simoncini, T.; Mannella, P.; Genazzani, A.R. 2003: Cardiovascular effects of selective estrogen receptor modulators. Current perspectives Recenti Progressi in Medicina 94(2): 51-56
Chandrasekar, B. 2000: Selective estrogen receptor modulators in coronary artery disease--are they here to stay? Indian Heart Journal 52(4): 487-490
Jensen, J.T. 2013: Vaginal ring delivery of selective progesterone receptor modulators for contraception Contraception 87(3): 314-318
Chetrite, G.ér.S.; Thole, H.H.; Philippe, J.-C.; Pasqualini, J.R. 2004: Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity Anticancer Research 24(3a): 1433-1438
Głuszko, R.ł; Zielezińska, K.; Ociepa, T.; Kamieńska, E.żb.; Chosia, M.; Urasiński, T.; Urasińska, E.żb.; Domagała, W. 2011: Reed-Sternberg cells in classical Hodgkin lymphoma in children seem to be predominantly oestrogen receptor α negative and oestrogen receptor β positive Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 62(2): 79-83